FDA Approved: GILOTRIF — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Gilotrif (afatinib) from Boehringer Ingelheim for patients with metastatic non-small cell lung cancer whose tumors have activating EGFR mutations. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gilotrif (Afatinib)

Snippet

ORIG AP for GILOTRIF (AFATINIB)